These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22032094)

  • 1. Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations.
    Fischer B; Jeffries V; Hall W; Room R; Goldner E; Rehm J
    Can J Public Health; 2011; 102(5):324-7. PubMed ID: 22032094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.
    Fischer B; Russell C; Sabioni P; van den Brink W; Le Foll B; Hall W; Rehm J; Room R
    Am J Public Health; 2017 Aug; 107(8):e1-e12. PubMed ID: 28644037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update.
    Fischer B; Robinson T; Bullen C; Curran V; Jutras-Aswad D; Medina-Mora ME; Pacula RL; Rehm J; Room R; van den Brink W; Hall W
    Int J Drug Policy; 2022 Jan; 99():103381. PubMed ID: 34465496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil.
    Fischer B; Malta M; Messas G; Ribeiro M
    Braz J Psychiatry; 2019; 41(6):550-555. PubMed ID: 31116260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lower-Risk Cannabis Use Guidelines' (LRCUG) recommendations: How are Canadian cannabis users complying?
    Lee CR; Lee A; Goodman S; Hammond D; Fischer B
    Prev Med Rep; 2020 Dec; 20():101187. PubMed ID: 33083205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.
    Fischer B; Daldegan-Bueno D; Bell R; Boden JM; Bullen C; Farrell M; Hall W; Newcombe D
    Public Health Pract (Oxf); 2020 Nov; 1():100046. PubMed ID: 36101675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower risk cannabis use guidelines: for whom?
    Erickson PG
    Can J Public Health; 2011; 102(5):328-9. PubMed ID: 22032095
    [No Abstract]   [Full Text] [Related]  

  • 8. What are the policy implications of the evidence on cannabis and psychosis?
    Hall W; Degenhardt L
    Can J Psychiatry; 2006 Aug; 51(9):566-74. PubMed ID: 17007223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging adult perceptions of higher-risk cannabis consumption behaviours.
    McMahon I; Harris-Lane LM; Donnan J; Bishop L; Harris N
    Harm Reduct J; 2023 Sep; 20(1):127. PubMed ID: 37679733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review.
    Hudson A; Hudson P
    Clin Gerontol; 2021; 44(1):3-15. PubMed ID: 32862795
    [No Abstract]   [Full Text] [Related]  

  • 11. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
    Fischer B; Murphy Y; Rudzinski K; MacPherson D
    Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to cannabis use disorder in primary care: focus on youth and other high-risk users.
    Turner SD; Spithoff S; Kahan M
    Can Fam Physician; 2014 Sep; 60(9):801-8, e423-32. PubMed ID: 25217674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the use of digital technologies to reduce the public health impacts of cannabis legalization in Canada.
    Bedrouni W
    Can J Public Health; 2018 Dec; 109(5-6):748-751. PubMed ID: 30097890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adverse health effects of cannabis use: what are they, and what are their implications for policy?
    Hall W
    Int J Drug Policy; 2009 Nov; 20(6):458-66. PubMed ID: 19362460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey.
    Fischer B; Rehm J; Irving H; Ialomiteanu A; Fallu JS; Patra J
    Int J Methods Psychiatr Res; 2010 Jun; 19(2):110-24. PubMed ID: 20506447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six policy lessons relevant to cannabis legalization.
    Shover CL; Humphreys K
    Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabis use in Canada: the need for a 'public health' approach.
    Fischer B; Rehm J; Hall W
    Can J Public Health; 2009; 100(2):101-3. PubMed ID: 19839283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of Cannabis Policy Liberalization With Alcohol Use and Co-Use With Cannabis: A Narrative Review.
    Pacula RL; Smart R; Lira MC; Pessar SC; Blanchette JG; Naimi TS
    Alcohol Res; 2022; 42(1):06. PubMed ID: 35360879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities.
    Fischer B; Imtiaz S; Rudzinski K; Rehm J
    J Public Health (Oxf); 2016 Mar; 38(1):183-8. PubMed ID: 25630540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for a feasibility study investigating the UCalgary's
    Mader J; Smith JM; Smith J; Christensen DR
    BMJ Open; 2020 Feb; 10(2):e032651. PubMed ID: 32051305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.